HAPPENING NOW
Health · 1 views
2018 to 2024 saw rise in insurance denials for brand-name drugs
Insurance denials of initial attempts to fill brand-name prescription drugs with no generic competitors increased by more than two-thirds…
AI Summary
Insurance denials of initial attempts to fill brand-name prescription drugs with no generic competitors increased by more than two-thirds from 2018 to 2024, according to a study published online in the Journal of the American Medical Association.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage
- Latest evidence on risk factors, early intervention, and strategies to prevent heart failure before symptoms developContinue reading
- RFK Jr. says cyclosporiasis is "under control," denies that cutbacks have hurt food safetyContinue reading
- Research suggests more patients with pre-existing disabilities could benefit from thrombectomyContinue reading